title: Inhaled nitric oxide in the preoperative evaluation of pulmonary hypertension in heart transplant candidates.
abstract: OBJECTIVE
  The goal of this study was to evaluate the efficacy of 100% oxygen and inhaled nitric oxide (iNO) in decreasing pulmonary vascular resistance (PVR) and transpulmonary gradient (TPG) in dilated cardiomyopathy patients being evaluated for orthotopic heart transplantation (OHT); who, despite maximal intravenous (IV) dilator therapy, had persistent moderate-to-severe pulmonary hypertension.
  
  
  METHODS
  A prospective nonrandomized clinical study.
  
  
  METHODS
  University hospital, major transplant center.
  
  
  METHODS
  Twenty-one adult patients undergoing OHT evaluation.
  
  
  METHODS
  One hundred percent oxygen and iNO at 20 and 40 ppm were sequentially administered to the patients once they were optimized with IV vasodilators and inotropes.
  
  
  RESULTS
  Although no significant change was noted with oxygen, iNO 20 ppm reduced the mean pulmonary artery pressure (44.1 +/- 1.7 to 38.6 +/- 1.8 mmHg, p < 0.05), PVR index (823 +/- 47 to 621 +/- 55 dyne/s/m(2)/cm(5), p < 0.05), TPG (22.4 +/- 1.4 to 17.0 +/- 1.5 mmHg, p < 0.05), and right ventricular stroke work index (14.7 +/- 1.2 to 11.1 +/- 1.2 g . m/m(2)/beat, p < 0.05). In 13 of 21 patients, PVR decreased by greater than 25% after iNO therapy. Nine of these patients had PVR and TPG decrease to levels considered acceptable for OHT listing.
  
  
  CONCLUSIONS
  iNO can further improve right ventricular hemodynamics even after presumed optimization with IV vasodilators and serves as a test of PVR reversibility during the preoperative assessment of OHT candidates.
authors.affiliation: Department of Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. amahajan@mednet.ucla.edu
authors.forename: Aman
authors.initials: A
authors.lastname: Mahajan
authors.forename: Afshin
authors.initials: A
authors.lastname: Shabanie
authors.forename: Shalini M
authors.initials: SM
authors.lastname: Varshney
authors.forename: Jure
authors.initials: J
authors.lastname: Marijic
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Sopher
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000601:surgery; D045462:Endothelium-Dependent Relaxing Factors / Q000008:administration & dosage; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000008:administration & dosage*; D010100:Oxygen / Q000008:administration & dosage; D011300:Preoperative Care / Q000379:methods*; D011446:Prospective Studies; D011651:Pulmonary Artery / Q000187:drug effects* / Q000503:physiopathology; D013318:Stroke Volume / Q000187:drug effects; D016896:Treatment Outcome; D014655:Vascular Resistance / Q000187:drug effects; D016278:Ventricular Function, Right / Q000187:drug effects*
chemical_list: D045462:Endothelium-Dependent Relaxing Factors; D009569:Nitric Oxide; D010100:Oxygen